OpenAlex
PricingAboutJobs
Log inGet started
Work

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

HTML PDF

Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetologia
DOI: 10.1007/s00125-006-0340-2
Authors: N. Matikainen, S. Mänttäri, A. Schweizer, A. Ulvestad, D. Mills, B. E. Dunning, J. E. Foley, M.-R. Taskinen
Institutions: Helsinki University Hospital, Novartis (Switzerland)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: DPP-4 inhibitors, type 2 diabetes, postprandial lipemia, triglyceride-rich lipoproteins, chylomicrons, apolipoprotein B-48, glucagon-like peptide-1, glucagon secretion, postprandial lipoprotein metabolism
SDG: Good health and well-being

Open Access status: bronze

Funder: Novartis Pharma
OpenAlex ID: W2152978153
FWCI: 12.5
Cites: 29
Cited by: 351
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security